XGN - Exagen inks agreement with Provider Network of America for AVISE tests

Exagen ([[XGN]] -4.6%) has entered into a preferred provider network agreement with Provider Network of America (‘PNOA’).PNOA is a nationwide, direct contracted provider network accessed by 526 payers, which has over 375,000 contracted physicians and 12,000 hospitals and ancillary facilities under contract, assuring reliable access to healthcare for providers, payers and patients.Under the terms of the agreement, over 8M PNOA members in the U.S. to have in-network access to Exagen’s unique suite of AVISE tests for autoimmune disorders, including rheumatoid arthritis and lupus.“This is an important step in securing Exagen’s reimbursement strategy framework for broad payer coverage, in-network access and widespread adoption of AVISE® testing as a standard of care,” stated Ron Rocca, President and CEO, Exagen.

For further details see:

Exagen inks agreement with Provider Network of America for AVISE tests